LFMD

LifeMD, Inc.
—

Company Information

Company Name
LifeMD, Inc.
CIK
CIK0000948320
Category
Accelerated filer
Ticker: Exchange
LFMD: Nasdaq, LFMDP: Nasdaq
Fiscal Year End
December 31
Owner Organization
08 Industrial Applications and Services
SIC
8011
SIC Description
Services-Offices & Clinics of Doctors of Medicine
Ticker
LFMD

SEC filing data through

Insider Sentiment

Last purchase
2024-09-11
Last sale
2025-12-09
Shares purchased (TTM)
0
Shares sold (TTM)
448,005
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
21,338,277
Shares outstanding
47,788,194
Ownership
44.65%
-7.41% Y/Y

Earnings Market Reaction

Filing date
2026-08-05
Price on filing date
—
1-month reaction
-14.67%
3-month reaction
Pending
Drift continued4/11 (36%)
Faded / reversed7/11 (64%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash2534-243634353836353315
Accounts Receivable Net Current1110997101066554
Deposits Assets Current000000000000
Inventory Net333333332234
Other Assets Current243422322111
Assets Current425252414950524945444325
Assets Noncurrent
Property Plant And Equipment Net222321111100
Operating Lease Right Of Use Asset555666673211
Capitalized Computer Software Net11111115151491313121211
Finite Lived Intangible Assets Net000222023333
Assets Noncurrent181819252524242419171616
Assets607070667474767364615841
Liabilities Current
Accounts Payable Current182214202416111615121110
Accrued Liabilities Current171516221519222115151415
Notes Payable Current--------0000
Operating Lease Liability Current111110000011
Convertible Debt Current----12128564--
Deferred Revenue Current1112111415171721151396
Liabilities Current475042576461675952453533
Long Term Debt Noncurrent
Convertible Debt Noncurrent----47101312141819
Operating Lease Liability Noncurrent566666672100
Business Combination Contingent Consideration Liability Noncurrent---000000000
Liabilities525547637374847966605352
Stockholders Equity
Preferred Stock Value000000000000
Common Stock Value000000000000
Additional Paid In Capital254253251249236233231227225221218197
Retained Earnings Accumulated Deficit-246-238-229-248-238-236-240-235-229-222-214-210
Treasury Stock Value-0-0-0-0-0-0-0-0-0-0-0-0
Stockholders Equity815231-2-5-8-8-414-13
Minority Interest---222222222
Liabilities And Stockholders Equity607070667474767364615841
Temporary Equity Par Or Stated Value Per Share----0.000.000.000.000.000.000.000.00
Temporary Equity Shares Authorized----55555555
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.00--0.000.000.00
Preferred Stock Shares Authorized5555555--555
Preferred Stock Liquidation Preference000---0-----
Common Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized100100100100100100100100100100100100
Common Stock Shares Issued484847474544424242413835
Shares Outstanding484847474544424242413835
Treasury Stock Common Shares000000000000

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

LifeMD, Inc. (LFMD) — SEC Financial Statements & Analysis

LifeMD, Inc. (LFMD) is a services-offices & clinics of doctors of medicine company, incorporated in DE. LifeMD, Inc. trades on Nasdaq as: LFMD, LFMDP. LifeMD, Inc. (LFMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, LifeMD, Inc. carries a market cap of $197.37M, a P/E ratio of -74.94x, a P/B ratio of 24.77x, a P/S ratio of 1.03x, an enterprise value of $172.22M, and an EV/EBITDA multiple of -9.02x. On profitability, it posts a gross margin of 87.50%, an operating margin of -10.54%, a net margin of -1.37%, a Return on Equity (ROE) of -85.18%, a Return on Assets (ROA) of -3.95%, and a Return on Invested Capital (ROIC) of -754.65%. Per share, it reports EPS of $-0.06, diluted EPS of $-0.06, free cash flow per share of $-0.23, and a dividend per share of $0.07. Over the trailing year, it posted revenue growth of 19.80% year-over-year, net income growth of -78.36% year-over-year, and EPS growth of -79.89% year-over-year. On the balance sheet, it maintains a current ratio of 0.90x, a quick ratio of 0.84x, working capital of $-4.52M, a debt-to-equity ratio of 6.52x, a debt ratio of 0.87, an interest coverage ratio of -51.73x, free cash flow of $-11.06M (TTM), and net debt of $-25.14M. Figures sourced from SEC EDGAR.

Market Cap
$197.37M
P/E TTM
-74.94x
EPS TTM
$-0.06
P/B TTM
24.77x
ROE TTM
-85.18%
ROA TTM
-3.95%
Debt To Equity
6.52x
Free Cash Flow TTM
$-11.06M
Net Revenue TTM Growth 1Y
19.80%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is LifeMD, Inc. in?

LifeMD, Inc. (LFMD) operates in the Services-Offices & Clinics of Doctors of Medicine industry.

What exchange does LFMD trade on?

LifeMD, Inc. (LFMD) trades on the Nasdaq.

Where is LifeMD, Inc. incorporated?

LifeMD, Inc. is incorporated in DE.

When was LifeMD, Inc. (LFMD)'s most recent SEC filing?

LifeMD, Inc. (LFMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.

What is LFMD's market cap?

LifeMD, Inc. (LFMD) has a market capitalization of $197.37M as of 2026-06-30.

What is LFMD's EPS (earnings per share)?

LifeMD, Inc. (LFMD)'s trailing twelve month EPS is $-0.06 as of 2026-06-30.

What is LFMD's ROE (return on equity)?

LifeMD, Inc. (LFMD)'s trailing twelve month Return on Equity (ROE) is -85.18% as of 2026-06-30.

What is LFMD's ROA (return on assets)?

LifeMD, Inc. (LFMD)'s trailing twelve month Return on Assets (ROA) is -3.95% as of 2026-06-30.

What is LFMD's ROIC (return on invested capital)?

LifeMD, Inc. (LFMD)'s trailing twelve month Return on Invested Capital (ROIC) is -754.65% as of 2025-12-31.

What is LFMD's EV/EBITDA?

LifeMD, Inc. (LFMD)'s trailing twelve month EV/EBITDA is -9.02x as of 2026-06-30.

Wall Street's data.
Main Street's price.